30.06.2021 • NewsNovasep

Novasep Modernizes Mourenx Site

French CDMO Novasep has announced plans to upgrade its API manufacturing facility in Mourenx, increasing its flexibility and competitiveness. The company will invest €6.1 million over three years and create seven full-time jobs.

“This investment sends a strong signal to our customers and partners by increasing our market competitiveness. It further supports our strategy of reinforcing our high-quality offer for the commercial production of innovative therapies,” said chairman and CEO Michel Spagnol.

The modernization of the cGMP workshop includes the installation of new equipment and the revamping of clean rooms for API isolation. Novasep said the investment will also allow it to develop high-performance capacity for the custom manufacturing of innovative therapeutic molecules.

In addition, the project has been selected as part of the France Relance recovery plan initiated by the French government. Novasep will be supported within the framework of the "Investissements d'Avenir" (Investments for the Future) program, which rewards innovative and promising industrial investments, in order to allow France to increase its economic growth and employment potential.

Last month, Novasep revealed it was planning to spend more than €4 million to expand manufacturing capabilities for highly potent active pharmaceutical ingredients at Le Mans in France.

Author: Elaine Burridge, Freelance Journalist

Novasep is to upgrade its API manufacturing facility in Mourenx, France,...
Novasep is to upgrade its API manufacturing facility in Mourenx, France, increasing its flexibility and competitiveness. The CDMO will invest €6.1 million over three years to install new equipment and revamp clean rooms for API isolation. It will also create seven new jobs. (c) Novasep

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.